Publications by authors named "Jeremy Frens"

Claim this Profile
R
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study.
Kaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, Nikki Tran, Taryn A Eubank, Jeremy Frens

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting rapid diagnostic test data into the appropriate hands by leveraging pharmacy staff and a clinical surveillance platform: a case study from a US community hospital.
Jeremy Frens, Tyler Baumeister, Emily Sinclair, Dustin Zeigler, John Hurst

J Antimicrob Chemother· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study.
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Jeremy J Frens

Infect Dis Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing transitions of care antimicrobial prescribing at a community teaching hospital.
Jordan Smith, Jeremy Frens, Dhaval Mehta, Kushal Naik, Emily Sinclair

Antimicrob Steward Healthc Epidemiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes.
Amer El Ghali, Taylor Morrisette, Sara Alosaimy, Kristen Lucas, Maria G Tupayachi-Ortiz, Jeremy J Frens

Antimicrob Agents Chemother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens.
Taylor Morrisette, Sara Alosaimy, Abdalhamid M Lagnf, Jeremy J Frens, Andrew J Webb

Infect Dis Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections.
Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, Jeremy J Frens

Open Forum Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a modified vancomycin nomogram for obese adults.
Nathan Batchelder, Carrie Faith Lutheran, Jeremy Frens

Eur J Clin Pharmacol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
Jordan R Smith, Jeremy J Frens, Cynthia B Snider, Kimberly C Claeys

Diagn Microbiol Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections.
Cassie L Stewart, Michelle S Turner, Jeremy J Frens, Cynthia B Snider, Jordan R Smith

Infect Dis Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis